{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:36:24Z","timestamp":1793230584422,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.amjcard.2017.12.025","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T13:55:39Z","timestamp":1515592539000},"page":"888-895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease"],"prefix":"10.1016","volume":"121","author":[{"given":"Ricky D.","family":"Turgeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-7915","authenticated-orcid":false,"given":"Glen J.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0708-7957","authenticated-orcid":false,"given":"Michelle M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.12.025_bib0010","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.107.726562","article-title":"Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0015","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.105.609990","article-title":"The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health\u2014National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation","volume":"114","author":"Shaw","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0020","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1161\/01.CIR.90.6.2695","article-title":"Acute effects of nitrates on exercise testing in patients with syndrome X: clinical and pathophysiological implications","volume":"90","author":"Lanza","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0002-9149(93)90683-4","article-title":"The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries","volume":"72","author":"Bugiardini","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0167-5273(95)02458-9","article-title":"Effect of diltiazem on coronary flow reserve in patients with microvascular angina","volume":"52","author":"Sutsch","year":"1995","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0035","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0735-1097(94)00507-M","article-title":"Cardiac syndrome X: clinical characteristics and left ventricular function: long-term follow-up study","volume":"25","author":"Kaski","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0045","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0050","series-title":"Cochrane Handbook for Systematic Review of Interventions Version 5.1.0","article-title":"Chapter 8: assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MCA.0b013e32830936bb","article-title":"The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X","volume":"20","author":"Erdamar","year":"2009","journal-title":"Coron Arterv Dis"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/hrt.77.1.32","article-title":"Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade","volume":"77","author":"Fragasso","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0065","first-page":"371","article-title":"Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X","volume":"9","author":"Sen","year":"2009","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0011-393X(02)80032-7","article-title":"Effects of lisinopril, atenolol, and isosorbide 5-mononitrate on angina pectoris and QT dispersion in patients with syndrome X: an open-label, randomized, crossover study","volume":"63","author":"Kanadasi","year":"2002","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0075","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0002-9149(99)00450-6","article-title":"Atenolol versus amlodipine versus isosorbide-5-mononitrate on angina symptoms in syndrome X","volume":"84","author":"Lanza","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0080","first-page":"1065","article-title":"Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance","volume":"44","author":"Leonardo","year":"1999","journal-title":"Cardiologia"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0085","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0002-9149(88)90232-9","article-title":"Verapamil versus acebutolol for syndrome X","volume":"62","author":"Romeo","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9149(85)90842-2","article-title":"Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve","volume":"56","author":"Cannon","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MCA.0000000000000054","article-title":"Effects of combination of statin and calcium channel blocker in patients with cardiac syndrome X","volume":"25","author":"Zhang","year":"2014","journal-title":"Coron Arterv Dis"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0100","first-page":"6","article-title":"Double-blind trial of nifedipine in angina patients with normal coronary arteries","volume":"3","author":"Pitcher","year":"1981","journal-title":"Pharmatherapeutica"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9149(96)00231-7","article-title":"Different effects of acute administration of aminophylline and nitroglycerin on exercise capacity in patients with syndrome X","volume":"78","author":"Radice","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-013-6439-z","article-title":"Lack of effect of nitrates on exercise stress test results in patients with microvascular angina","volume":"27","author":"Russo","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000370027","article-title":"Poor tolerance and limited effects of isosorbide-5-mononitrate in microvascular angina","volume":"130","author":"Wu","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0120","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/echo.12674","article-title":"Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease","volume":"32","author":"Tagliamonte","year":"2015","journal-title":"Echocardiography"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jcmg.2011.03.007","article-title":"Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease","volume":"4","author":"Mehta","year":"2011","journal-title":"J Am Coll Cardiol Imaging"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0130","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): Impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0135","first-page":"OC14","article-title":"Effect of ranolazine in patients with chest pain and normal coronaries: a hospital based study","volume":"11","author":"Saha","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0145","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9149(02)02664-4","article-title":"Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X","volume":"90","author":"Chen","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0150","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0735-1097(94)90750-1","article-title":"Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina","volume":"23","author":"Kaski","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000006768","article-title":"Therapeutic benefits of cilazapril in patients with syndrome X","volume":"89","author":"Nalbantgil","year":"1998","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0160","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.CIR.0000100722.34034.E4","article-title":"Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: role of superoxide dismutase activity","volume":"109","author":"Pizzi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/hrt.2006.089904","article-title":"The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X","volume":"93","author":"Russell","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0175","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amjcard.2004.05.035","article-title":"Effect of simvastatin on endothelial function in cardiac syndrome X patients","volume":"94","author":"Fabian","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0180","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0195-668X(03)00478-0","article-title":"Benefits of statin treatment in cardiac syndrome-X","volume":"24","author":"Kayikcioglu","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0185","doi-asserted-by":"crossref","first-page":"827","DOI":"10.5114\/aoms.2017.68238","article-title":"Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study","volume":"13","author":"Kabaklic","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0190","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00042192-200107000-00003","article-title":"Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms","volume":"8","author":"Adamson","year":"2001","journal-title":"Menopause"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0167-5273(96)02560-0","article-title":"Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X","volume":"54","author":"Albertsson","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0200","doi-asserted-by":"crossref","first-page":"987.e1","DOI":"10.1016\/j.ahj.2010.03.024","volume":"159","author":"Bairey Merz","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0205","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0735-1097(96)00348-8","article-title":"17-Beta-estradiol therapy lessens angina in postmenopausal women with syndrome X","volume":"28","author":"Rosano","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0210","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1053\/euhj.2001.2631","article-title":"Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries","volume":"22","author":"Sitges","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0215","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jacc.2006.04.088","article-title":"Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study","volume":"48","author":"Jadhav","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0220","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MCA.0b013e32835f3005","article-title":"\u03c9-3 Fatty acid treatment in cardiac syndrome X: a double-blind randomized, placebo-controlled clinical study","volume":"24","author":"Bozcali","year":"2013","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9149(97)00279-8","article-title":"Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina","volume":"80","author":"Chen","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0230","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijcard.2014.12.055","article-title":"Ranolazine: drug overview and possible role in primary microvascular angina management","volume":"181","author":"Cattaneo","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0235","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/clc.22660","article-title":"Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine","volume":"40","author":"Nelson","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0240","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): Developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.12.025_bib0245","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10557-016-6676-z","article-title":"Treatment of angina pectoris associated with coronary microvascular dysfunction","volume":"30","author":"Ong","year":"2016","journal-title":"Cardiovasc Drug Ther"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918300456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918300456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T15:50:47Z","timestamp":1535125847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918300456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0002914918300456"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.12.025","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}